AGC Biologics Partners with Teikoku Seiyaku for Lumbar Disc Therapy Development
Berlin: AGC Biologics has been selected by Teikoku Seiyaku Co Ltd to provide microbial contract development and manufacturing services for KTP-001, a recombinant human matrix metalloproteinase-7 (rhMMP-7) therapy being developed to treat lumbar disc h…